Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2013
Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade gliomaNorbert Galldiks, Gabriele Stoffels, Maximilian I Ruge, et al.
Nuclear Medicine and Biology|June 18, 2013
Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomasMarc D Piroth, Jeyakamalini Prasath, Antje Willuweit, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2017
Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR studyAntoine Verger, Christian P Filss, Philipp Lohmann, et al.
Neuroimage. Clinical|November 22, 2017
Evaluation of factors influencing 18F-FET uptake in the brainAntoine Verger, Carina Stegmayr, Norbert Galldiks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2012
Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosisNorbert Galldiks, Gabriele Stoffels, Christian P Filss, et al.
Neuroimage. Clinical|September 4, 2018
Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasisPhilipp Lohmann, Martin Kocher, Garry Ceccon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 2014
Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysisAna S Costa, Frances E Tiffin-Richards, Bernhard Holschbach, et al.
Neuro-Oncology|May 27, 2015
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent gliomaNorbert Galldiks, Gabriele Stoffels, Christian Filss, et al.
Pageof 7